IO BIOTECH INC (IOBT) Stock News

USA - NASDAQ:IOBT - US4497781090 - Common Stock

1.02 USD

+0.2 (+24.36%)

Last: 10/21/2025, 8:23:40 PM

0.9399 USD

-0.08 (-7.85%)

After Hours: 10/21/2025, 8:23:40 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

IOBT Latest News, Press Relases and Analysis

All

Press Releases

12 days ago - By: Chartmill - Mentions: SLE USNA VNRX APM ...

News Image

The market is filled with gapping stocks in Friday's session.

2 days ago - By: Benzinga - Mentions: XRTX REPL AZTR HSDT ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

2 days ago - By: IO Biotech

IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025

20 days ago - By: Benzinga - Mentions: BOLT SCLX TSHA RVPH ...

12 Health Care Stocks Moving In Thursday's Intraday Session

22 days ago - By: Stocktwits - Mentions: MRK

News Image

IO Biotech Stock Plunges After FDA Recommends Another Trial For Investigational Cancer Vaccine

23 days ago - By: IO Biotech

IO Biotech Provides Update Following Pre-BLA Meeting with FDA

a month ago - By: IO Biotech

IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025

2 months ago - By: IO Biotech

IO Biotech Announces Participation in Upcoming Investor Conferences

2 months ago - By: Zacks Investment Research

IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's What You Should Know

2 months ago - By: Yahoo Finance

H.C. Wainwright Reiterates Buy Rating on IO Biotech, Keeps PT at $14

2 months ago - By: The Motley Fool

Io Biotech Posts Wider Loss in Q2

2 months ago - By: IO Biotech

IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights

2 months ago - By: Stocktwits - Mentions: MRK

IO Biotech Stock Slumps After Trial Of Cancer Therapy Plus Keytruda Misses Study Goal: Retail Sees Shares Rise 10x